‘COMMONWEALTH OF MASSACHUSETS
Middlesex, SS Boetd of Repsaton in Medicine
Adjudlcatory CoseNo. 2021-045,
Inne Maer of
RAYMOND K, SAULS, MD.
CONSENT ORDER
Pursuant to GL. c.30A, § 10, Raymond K. Sauls, MD. (Respondent) andthe Bowd of
Registtion in Medicine (Boas) (erlnatr refered n oll asthe "Pra age thet the
‘Board may ia this Consent Order o resolve the above-cptioned adjudintry proceeding,
‘The Paes fuer agree that this Consent Order wil ave all he force and effect ofa Final
Decision within the meaning of 01 CMR 1,01(11X). The Respondent adits tothe findings of
fact specified below and apress that he Board many make the conclusions of law and impose the
saneton ot forth below in resolution of investigative Docket No, 17-050
Fini
1. The Respondent was born on April 6 1956, He graduated ftom the Autonomous
University of Gundalajara in Mexico in 1988, He has bea licensed to practice medicine in
-Matsachuotie wer cortfate number 76168 dace 1992, He has pvloges at Clinton Howgita
ad Teal Alliance.
Const adr Rayon Sa, 0. tot‘Massashunets Prescription Awareness Tool
2, ‘The Massachusetts Prescription Awareness Tool (Masi? AT) is en online database
hat ists al Schedule It V presritions au well ay gabapentin preseriptions filled by pation at
paces.
5, Beginning on or ubout December 5, 21
ysiians wore required to check
“Mase prior opreseribing opioids listed n Schedles It nd 1,
Pasa A
4. Palen Ain mate born in 1975
5. in Apsi!2009, the Responder bsame Pasient A's Pim Cue Physician (PCP),
6, inDecerber 200, the Respondent bepan esting Patient A with Schedule It
opioids fr tack pao.
7. ImMarch 2010, tho Respondent bepan treating Patent A’s ensity with
bensodnzpines which are Schedule LV mediatons.
1, Paien A's history of depression, aleholsbuse nd abuse other aubstarees made
‘im a igh isk for preserpton opiate abuse
9, Combining opioid with benzodiazepines inreases tho risk of ovendose
10. The Respondent filed to document rk-heneit conversations with Patient A
regarding the combination of bezoelazepnes and opis
11, From Docomber S,2014 fo February 2019, the Respondent filed to query
MassPAT when prescribing opioids to Patient A.
12, The Respondent fled to order wie dug ts fr Patient A.
conn Ont Raymond Say, MD, dottPavers
13, Patent Bisa female born in 1972,
14, InNoverber 1996, the Respondent bocame Patient B's PCP.
15. tm August 2008 he Respondent bepan wean Paint B's bck pala with
Sobedale I opioids and Patient B's anxiety wit benzodiazepines
16. Paint B's history of depression, ADHD, cocaine abuse, an childhood trauma i
‘made he high isk for prescription opiate abuse,
V7, Tho Respondent fled to document rik-benafitcoaversation wth Patient B
regarding the combination of benzodiazepines and opioids
18, From December 5,2014 1 February 2018, tbe Respondent led to query
MasePAT when preseibng opioids to Petia
19, The Respondent led to order re drug tests fr Paint B
Paulent ¢
20, Patent C was a fra bora in 1973.
21, 1n1997, the Respondent bese Patent Cs PCP.
22, In Janory 2003, the Respondent began pressing Pent Copii fr pu,
23, By Auguat2013, he Respondent was treating Paton C with Sohedule I plod.
24, tn October 2014 the Respondent bog prescribing Patient benendianpins for
sanity,
28, Patent C'e history afencsine se slebol abuse, een abuse aul depression
made er igh ik or prenerpton opiate abu,
26, The Respondent filed to documontrisk-benfit conversations with Patient C
regia to oombinatton of benzodlazopaes ead opioids.
ons rr Raymond Sai MD. aot?21, From December 5, 2014 to February 2019, the Respondent filed to query
‘MassPAT when prescibing opoid a Patient C,
28, The Respondent filled to order un dug tess for Patent C.
29, The Respondeat filed to follow the standard of caro when wean ho above
hrc patients.
Pavent
30. Patient Disa female bora in 1985,
31, 2000 the Respondent became Patent D's PP.
32, in 2007 the Respondent began presarbing Patient D Schedule Ul opos or her
back pai,
538, From December 5, 2014 fo Fetrery 2019, ho Respondent filed to query
MassPAT when preseting opioids to Patent D,
Patent
34. Palent 8 yas. male torn in 1970.
35, 1n2009, the Respondent became Patient B's PCP.
136. 1n2010, the Respondent began prescribing Patent E Schodle opioids for
chronic ain,
37, From December 5, 2014 to February 2019, the Respondent led to qury
MassPAT when pesoibng opioids to Patient
Come Order Rayna, MD sortConstusion ofa
‘A, The Respondent has woleted GL. 6112, 5, cg pt (e) and 243 CMR
1,03(5,08 by engaging in conduct hat ples ato question the Respondents competence to
practie modtelne ineibng prt mein wih neylgsace una sepontl oecesions.
1B, Porouant to
L. 6512, $5, eighth par (0), and 243 CMR. 1.03(5KA)1, the
Board may disepline a physician upon roof satsfictoy to «mani ofthe Board that sid
Dysician has commited wn offense against ny provisions ofthe laws ofthe Commonwelih
reiting tothe practice of medicine, o ny rule ot regulation adopted tere, to wit:
1.105 CMR 700.00 a5 petnns to mandatory review ofthe MassPAT system
forthe isuance oferta preseptios,
‘Sanction and Order
‘The Respondents lcene i oteby REPRIMANDED. A permanent eens resticton is
lao Snposel pursuant MG c, M2, 8, SA und 243 CMR. 1.05(7) tht probit the
Respondent from proseibing controled substances in Schedules and IV. This nstion fs
imposed fr each voaton of aw listed inthe Conclusion section end not a combination of ey
oral ofthe,
Tccution ofthis Consent Onder
‘Complaint Counsel and the Respondent agro that the approval ofthis Consent Onder
1ufto the discretion of he Board, The sigaatue of Complaint Counsel the Respondent, an the
espns amanenl at expel cotoned on the Bose soaring his Consent Onde, If
te Board tet this Consent Orrin whole orn pst thon the ete document shal be ml
and vod teeter, thr ofthe partis nor anyone else may rely on thse stipulations in his
contest d= Raye Sai, MD. sort‘Asto any mater in this Consent Orde eft to the discretion ofthe Board, ether he
Respondent or anyone acting on her behalf, bas received any promises or epeseniations
regarding he same,
“The Responsdont waives ny sight of eppoel hat ha may have ret fom the Borde
acceptance ofthis Consent Orr,
“The Respondent ll provide a complete copy ofthis Consent with al exhibits and
stachents within ten (10) days by ceitid mal rem eel requested, o by hand detivery
to the following designated enter: any hoe outostate bos, musing home clinic, other
licensed fait, or muni, sate, or federal faclty at which oe practives mein; any t=
or outoestate health maintenance orpaniation with whom the Respondent hus privileges or any
other kindof asocation; any state agency, in-out with whic the Respondent has @
provider contrat any in-o otofsate modal employer, whether or not the Respondent
praties mliine there; estate licensing boards of al states in which the Respondent bas eny
kind of cee to prctce madi; dh Drug Enforcement Adminiation Boston Diversion
(Group and the Massachusetts Departinent of Publi Health Drug Control Program, The
Respondent al also provide this ntifcaon to way such designate ents with which the
Respondent become sss forthe duration ofthis precicereariction. The Respondeat is
fiber deste to cent 1 the Boa within ten (10) day thatthe Respondent has complied
with this dective.
“The Board exprossy reserves the shor f independently not ten time, exy oF
tho entitles designated above or any oter affected entity, of any ation it has taken.
Conn eran Sa, MD GorBL wan
Raymond & Saas, MD.
Hisense
Lopee
ys is lal
ako
Complaint Counsel,
‘SoORDERED by the Board of Regstmon in Medicine hisheh day of November
- Te
Seg
AHR
Julian Robinson, M.D.
Board chair
consent Oe yond Sl, MLO. re